ResMed (RMD) Tops Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $192.91 -1.48%
Revenue Growth %: +13.1%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
HYFT, ESBS, PFBK, More
Revenue Growth %: +13.1%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
HYFT, ESBS, PFBK, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
- NB Bancorp, Inc. (NBBK) Tops Q2 EPS by 14c
- Bernstein SocGen Group Upgrades Sona BLW Precision (SONACOMS:IN) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
